Roche, Allergan Sue Apotex Again Over Acular Patent
Swiss drug maker Roche and licensee Allergan Inc. have sued Canadian generics maker Apotex in a California federal court over its plans to make a generic version of the eye-inflammation treatment...To view the full article, register now.
Already a subscriber? Click here to view full article